← Back to Search

Remote Blood Pressure Monitoring for High Blood Pressure

Waitlist Available
Led By Catherine Sarkisian, MD, MSHS
Research Sponsored by University of California, Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Takes zero or one antihypertensive medication.
Aged 18 years and older
Screening 3 weeks
Treatment Varies
Follow Up baseline, six months
Awards & highlights
No Placebo-Only Group

Study Summary

This trial is testing two ways to help people with hypertension monitor their blood pressure at home, to see if it can help lower blood pressure overall.

Who is the study for?
This trial is for adults with high blood pressure who use a non-connected blood pressure cuff at home, take up to three antihypertensive medications, and can access an online healthcare portal. They should have had two high BP readings in the last year and seen their primary care physician within that time. People with severe hypertension or certain health conditions like advanced kidney disease or recent heart problems cannot participate.Check my eligibility
What is being tested?
The study compares two remote monitoring methods for managing high blood pressure: one where patients manually record their BP and report it, versus another where the readings are automatically sent to their health system. The goal is to see which method better controls blood pressure across different University of California locations.See study design
What are the potential side effects?
Since this trial focuses on monitoring methods rather than medication changes, side effects are not a primary concern here. However, participants may experience stress or inconvenience related to using the technology or any potential technical issues.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
I take one or no blood pressure medications.
I am 18 years old or older.
I am willing and able to use a remote blood pressure monitor and a manual cuff at home, with help if needed.
I have high blood pressure with two readings above the normal range.
I take up to three blood pressure medications.


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, six months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, six months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Continuous change in blood pressure (BP)
Secondary outcome measures
Body Weight Changes
Binary measure of controlled vs uncontrolled hypertension
Changes in blood pressure (BP) outcomes from integrated monitor readings
+1 more
Other outcome measures
Adverse events

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: IntegratedExperimental Treatment1 Intervention
Participants will have their home blood pressure readings sent directly to their participating health systems. Participants will also receive a wrap-around intervention.
Group II: ManualActive Control1 Intervention
Participants will record their own blood pressures and report them to their health care system as per usual care.

Find a Location

Who is running the clinical trial?

University of California, Los AngelesLead Sponsor
1,509 Previous Clinical Trials
10,283,944 Total Patients Enrolled
University of California Office of the President- Quality and Population Health ManagementUNKNOWN
University of California, DavisOTHER
902 Previous Clinical Trials
5,036,345 Total Patients Enrolled

Media Library

integrated monitoring and local wrap-around hypertension program Clinical Trial Eligibility Overview. Trial Name: NCT05390502 — N/A
High Blood Pressure Research Study Groups: Integrated, Manual
High Blood Pressure Clinical Trial 2023: integrated monitoring and local wrap-around hypertension program Highlights & Side Effects. Trial Name: NCT05390502 — N/A
integrated monitoring and local wrap-around hypertension program 2023 Treatment Timeline for Medical Study. Trial Name: NCT05390502 — N/A
High Blood Pressure Patient Testimony for trial: Trial Name: NCT05390502 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there still an opportunity to join the research for this project?

"This specific trial, which was initially posted on January 1st 2023 and last updated in November 2022 is not presently looking for participants. However, there are 745 other medical trials that are currently open to enrollment."

Answered by AI

Who else is applying?

What state do they live in?
What site did they apply to?
University of California, Los Angeles
What portion of applicants met pre-screening criteria?
Did not meet criteria
How many prior treatments have patients received?

Why did patients apply to this trial?

I have extremely high blood pressure and am not taking any meds.
PatientReceived 2+ prior treatments
~360 spots leftby Feb 2025